US drug tariff risk limited for Indian pharma; Sun Pharma exposure in focus: Vishal Manchanda

US drug tariff risk limited for Indian pharma; Sun Pharma exposure in focus: Vishal Manchanda

Vishal Manchanda, Pharma Analyst, Systematix Group, said potential US tariffs on pharmaceuticals are unlikely to have a broad impact on Indian drug makers, as the focus remains on branded and patented medicines. The comments come amid reports that the US President Donald Trump administration may consider tariffs on drug companies that have not agreed to…

Read More
PNB Q4 update: Loan growth strong, CASA ratio improves; global biz up 11%

PNB Q4 update: Loan growth strong, CASA ratio improves; global biz up 11%

Punjab National Bank reported steady growth in its March quarter business update, with expansion across loans, deposits and overall business. Global total business rose 10.79% year-on-year and 2.81% sequentially to ₹29.72 lakh crore. Total global deposits increased 9.25% year-on-year to ₹17.11 lakh crore, while gross advances grew 12.97% to ₹12.61 lakh crore. On the domestic…

Read More
GR Infraprojects bags ₹1,898 crore EPC contract from West Central Railway

GR Infraprojects bags ₹1,898 crore EPC contract from West Central Railway

G R Infraprojects Ltd has signed an engineering, procurement and construction (EPC) agreement worth ₹1,898 crore with West Central Railway, further strengthening its order book. The latest contract adds to a series of project wins for the company in recent weeks, indicating sustained order inflows across segments. Earlier, the company received a Letter of Acceptance…

Read More